Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1338-1343

  Lee, Kyung Mi ^a,b   Lee, Dong Eun ^a,b   Seo, Sang Kwon ^a   Hwang, Mun Kyung ^a,b   Heo, Yong Seok ^b   Lee, Ki Won ^b   Lee, Hyong Joo ^a  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAEMPFEROL; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; ULTRAVIOLET B RADIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMIS; KAEMPFEROLS; LUCIFERASES; MICE; MODELS, MOLECULAR; NF-KAPPA B; PLASMIDS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 77955351266     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq102     Document Type: Article

References (35)

1. Cantley,L.C. (2002) The phosphoinositide 3-kinase pathway. Science, 296, 1655-1657.
2. Fresno Vara,J.A. et al. (2004) PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev., 30, 193-204.
3. Vivanco,I. et al. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2, 489-501.
4. Nomura,M. et al. (2003) Involvement of the Akt/mTOR pathway on EGFinduced cell transformation. Mol. Carcinog., 38, 25-32.
5. Huang,C. et al. (1996) Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol., 16, 6427-6435.
6. Li,J.J. et al. (1997) Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57, 3569-3576.
7. Dong,Z. et al. (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA, 91, 609-613.
8. Darnell,J.E., Jr. (2002) Transcription factors as targets for cancer therapy. Nat. Rev. Cancer, 2, 740-749.
9. Bode,A.M. et al. (2000) Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol., 1, 181-188.
10. Gilmore,T.D. (1997) Clinically relevant findings. J. Clin. Invest., 100, 2935-2936.
11. Ouyang,W. et al. (2006) Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis, 27, 864-873.
12. Chen,F. et al. (2000) Participation of MAP kinase p38 and IkappaB kinase in chromium (VI)-induced NF-kappaB and AP-1 activation. J. Environ. Pathol. Toxicol. Oncol., 19, 231-238.
13. Gilmore,T.D. et al. (1996) Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene, 13, 1367-1378.
14. Havsteen,B.H. (2002) The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 96, 67-202.
15. Moriyama,H. et al. (2003) Antiinflammatory activity of heat-treated Cassia alata leaf extract and its flavonoid glycoside. Yakugaku Zasshi, 123, 607-611.
16. Della Loggia,R. et al. (1988) Anti-inflammatory activity of benzopyrones that are inhibitors of cyclo-and lipo-oxygenase. Pharmacol. Res. Commun., 20 (suppl. 5), 91-94.
17. Dimas,K. et al. (2000) Cytotoxic activity of kaempferol glycosides against human leukaemic cell lines in vitro. Pharmacol. Res., 41, 83-86.
18. Cho,Y.Y. et al. (2007) Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res., 67, 8104-8112.
19. Smith,J.A. et al. (2006) Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK. Bioorg. Med. Chem., 14, 6034-6042.
20. Cho,Y.Y. et al. (2009) A regulatory mechanism for RSK2 NH(2)-terminal kinase activity. Cancer Res., 69, 4398-4406.
21. Colburn,N.H. et al. (1982) Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies. J. Cell. Biochem., 18, 261-270.
22. Colburn,N.H. et al. (1981) Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc. Natl Acad. Sci. USA, 78, 6912-6916.
23. Sasaki,T. et al. (1996) Focal adhesion kinase (p125FAK) and paxillin are substrates for sphingomyelinase-induced tyrosine phosphorylation in Swiss 3T3 fibroblasts. Biochem. J., 315 (Pt), 31035-1040.
24. Ahn,M.R. et al. (2004) Antioxidant activity and constituents of propolis collected in various areas of Korea. J. Agric. Food Chem., 52, 7286-7292.
25. Park,J.S. et al. (2006) Enzymatic preparation of kaempferol from green tea seed and its antioxidant activity. J. Agric. Food Chem., 54, 2951-2956.
26. Bestwick,C.S. et al. (2007) Kaempferol induced inhibition of HL-60 cell growth results from a heterogeneous response, dominated by cell cycle alterations. Chem. Biol. Interact., 170, 76-85.
27. Leung,H.W. et al. (2007) Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem. Toxicol., 45, 2005-2013.
28. Baldwin,A.S., Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-683.
29. Finco,T.S. et al. (1997) Oncogenic Ha-Ras-induced signaling activates NFkappaB transcriptional activity, which is required for cellular transformation. J. Biol. Chem., 272, 24113-24116.
30. Krasilnikov,M.A. (2000) Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc.), 65, 59-67.
31. Macara,I.G. et al. (1984) Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. Proc. Natl Acad. Sci. USA, 81, 2728-2732.
32. Brazil,D.P. et al. (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci., 29, 233-242.
33. Kabuyama,Y. et al. (1998)Wavelength specific activation of PI 3-kinase by UVB irradiation. FEBS Lett., 441, 297-301.
34. Walker,E.H. et al. (1999) Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature, 402, 313-320.
35. Walker,E.H. et al. (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell, 6, 909-919.